Literature DB >> 15147216

Identification of novel in vivo phosphorylation sites in high mobility group N1 protein from the MCF-7 human breast cancer cells.

Yan Zou1, Xinzhao Jiang, Yinsheng Wang.   

Abstract

High mobility group N1 (HMGN1) protein is a member of nonhistone chromosomal proteins that binds more strongly with nucleosomes than with DNA. Here we report the identification of the sites of in vivo phosphorylation of HMGN1 isolated from the MCF-7 human breast cancer cells. Our results showed that four serine residues, i.e., Ser6, Ser85, Ser88, and Ser98, can be phosphorylated in this protein. To our knowledge, this is the first demonstration that each of the three serine residues in the acidic C-terminal region of human HMGN1 can be phosphorylated. The additional negative charge resulting from the phosphorylation of the C-terminal serine residues is expected to modulate the interaction between HMGN1 and other proteins, which may enhance transcription and facilitate other cellular functions. In addition, the phosphorylation of HMGN1 at Ser85, which precedes Pro86, might play an important role in cellular signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147216     DOI: 10.1021/bi0362828

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

Review 1.  High mobility group proteins and their post-translational modifications.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2008-05-10

Review 2.  Transcriptional regulation by HMGN proteins.

Authors:  Nan Zhu; Ulla Hansen
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

Review 3.  HMG modifications and nuclear function.

Authors:  Qingchun Zhang; Yinsheng Wang
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

4.  Proteome and Phosphoproteome Changes Associated with Prognosis in Acute Myeloid Leukemia.

Authors:  Elise Aasebø; Frode S Berven; Sushma Bartaula-Brevik; Tomasz Stokowy; Randi Hovland; Marc Vaudel; Stein Ove Døskeland; Emmet McCormack; Tanveer S Batth; Jesper V Olsen; Øystein Bruserud; Frode Selheim; Maria Hernandez-Valladares
Journal:  Cancers (Basel)       Date:  2020-03-17       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.